Vor Biopharma Inc. (VOR) Misses Q3 EPS by 12150c
Tweet
Share
E-mail
Get Alerts VOR Hot Sheet
Join SI Premium – FREE
Vor Biopharma Inc. (NASDAQ: VOR) reported Q3 EPS of ($121.60), $121.50 worse than the analyst estimate of ($0.10).
For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: Walmart will be lowering prices
- Nvidia underperforms peers as report sparks rack delay worries
- Goldman Sachs Downgrades Ferguson Plc. (FERG) to Neutral, 'We now see better opportunities elsewhere in our coverage'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
